Relationship between Primary Payer and Use of Proactive Immunization Practices: A National SurveyByRichard K. Zimmerman, MD, MPH,Tammy A. Mieczkowski, PhD,Mahlon Raymund, PhDMay 1st 1999
Polypharmacy Management in Medicare Managed Care: Changes in Prescribing by Primary Care Physicians Resulting from a Program Promoting Medication ReviewsByHoward Fillit, MD,Robert Futterman, PhD,Burton I. Orland, RPh,Terrence Chim, RPh,Lawrence Susnow, MD,Gloria Picariello, RN,Eileen C. SMay 1st 1999
Course and Cost of Treatment for Depression with Fluoxetine, Paroxetine, and SertralineByJames M. Russell, MD,Ernst R. Berndt, PhD,Robert Miceli, PhD,Salvatore Colucci, MS,Amy N. Grudzinski, PharmDMay 1st 1999
Project LEAP of New Jersey: Lower Extremity Amputation Prevention in Persons with Type 2 DiabetesByMarc Bruckner, DPM,Mavourneen Mangan, RN,Steven Godin, PhD, MPH,Leonard Pogach, MDMay 1st 1999
Quality of Care for Chronic Illness in Primary Care: Opportunities for Improvement in Process and Outcome MeasuresBySteven M. Ornstein, MD,Ruth G. Jenkins, MSMay 1st 1999
Assessment of Patient Satisfaction with a Formulary Switch from Omeprazole to Lansoprazole in Gastroesophageal Reflux Disease Maintenance TherapyByLaura J. Condra, PharmD,Anthony P. Morreale, PharmD, BCPS, MBA,Stephen N. Stolley, PharmD, BCPS,David Marcus, RPhMay 1st 1999
Overview of Platelet Glycoprotein IIb/IIIa Receptor Antagonist Treatment in the Management of Coronary Interventions and Acute Ischemic Coronary SyndromesByOlga Bessmertny, BS,Judy W.M. Cheng, PharmD, BCPSMay 1st 1999
Benign Prostatic Hyperplasia: An Overview for PharmacistsByJoanna Labreque, PharmD,Richard Randolph, PharmD,Roger Davis, PharmDMay 1st 1999
Correspondence regarding, "How Should Managed Care Treat Onychomycosis?"ByJames Q. DelRosso,Author reply by H. Irving KatzMay 1st 1999
